1. Home
  2. PLRX vs HTBI Comparison

PLRX vs HTBI Comparison

Compare PLRX & HTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • HTBI
  • Stock Information
  • Founded
  • PLRX 2015
  • HTBI 1926
  • Country
  • PLRX United States
  • HTBI United States
  • Employees
  • PLRX N/A
  • HTBI N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • HTBI Savings Institutions
  • Sector
  • PLRX Health Care
  • HTBI Finance
  • Exchange
  • PLRX Nasdaq
  • HTBI Nasdaq
  • Market Cap
  • PLRX 680.3M
  • HTBI 641.9M
  • IPO Year
  • PLRX 2020
  • HTBI 2012
  • Fundamental
  • Price
  • PLRX $12.33
  • HTBI $37.25
  • Analyst Decision
  • PLRX Strong Buy
  • HTBI Buy
  • Analyst Count
  • PLRX 7
  • HTBI 4
  • Target Price
  • PLRX $40.50
  • HTBI $39.00
  • AVG Volume (30 Days)
  • PLRX 485.5K
  • HTBI 42.1K
  • Earning Date
  • PLRX 02-26-2025
  • HTBI 01-23-2025
  • Dividend Yield
  • PLRX N/A
  • HTBI 1.30%
  • EPS Growth
  • PLRX N/A
  • HTBI N/A
  • EPS
  • PLRX N/A
  • HTBI 3.20
  • Revenue
  • PLRX N/A
  • HTBI $193,436,000.00
  • Revenue This Year
  • PLRX N/A
  • HTBI N/A
  • Revenue Next Year
  • PLRX N/A
  • HTBI $3.67
  • P/E Ratio
  • PLRX N/A
  • HTBI $11.33
  • Revenue Growth
  • PLRX N/A
  • HTBI 4.69
  • 52 Week Low
  • PLRX $10.22
  • HTBI $23.55
  • 52 Week High
  • PLRX $18.00
  • HTBI $38.99
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 47.63
  • HTBI 61.69
  • Support Level
  • PLRX $10.35
  • HTBI $35.68
  • Resistance Level
  • PLRX $11.07
  • HTBI $38.22
  • Average True Range (ATR)
  • PLRX 0.55
  • HTBI 1.07
  • MACD
  • PLRX 0.11
  • HTBI 0.30
  • Stochastic Oscillator
  • PLRX 55.75
  • HTBI 81.24

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About HTBI HomeTrust Bancshares Inc.

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products.

Share on Social Networks: